Mutual Non-Disclosure,
Non-Circumvention,
and AI Confidentiality Agreement
This Agreement is entered into as of the date last signed below (the "Effective Date") by and between AInforce, Inc., a Delaware corporation with its principal place of business at [ADDRESS] ("AR"), and the undersigned counterparty ("Company"). AR and Company are each a "Party" and together the "Parties."
The Parties wish to explore, evaluate, negotiate, or perform a potential business relationship, including without limitation a customer, partner, vendor, integration, reseller, advisory, investor, or pilot relationship (the "Purpose"). AR is an AI security and governance software company whose valuable assets include AI security architecture, agent control-plane methods, model and agent telemetry, policy enforcement runtimes, prompt-injection defenses, MCP implementations and inspectors, tool firewalls, detection logic, product strategy, customer and prospect relationships, pricing methodology, security methodologies, data-classification methods, red-team findings, cost and ROI analytics, and other trade secrets.
"Confidential Information" means all non-public information disclosed or made available by a Party (the "Disclosing Party") to the other Party (the "Receiving Party"), whether before or after the Effective Date and whether oral, written, electronic, visual, machine-readable, API-based, system-generated, or in any other form. Includes without limitation: business plans, financial information, pricing, discounts, forecasts, product roadmaps, software and source code, AI models, model weights, prompts, prompt chains, embeddings, vector databases, detection logic, policy rules, customer and prospect information, personnel information, security vulnerabilities and remediation, technical architecture, API structures and endpoints, data schemas, system configurations, red-team findings, pilot and evaluation outputs, telemetry, training data, intellectual property, and any information marked "Confidential," "Proprietary," or "Restricted."
Information disclosed orally or visually is Confidential Information if identified as such at disclosure or if a reasonable person would understand it to be confidential given its nature and circumstances.
"Highly Confidential Information" means Confidential Information that is especially sensitive or competitively significant, including: source code; unpublished product or security architecture; AI models, model weights, prompts, prompt libraries, embeddings, and vector databases; detection logic; policy enforcement rules; MCP or agent-control-plane configurations; customer and prospect lists; pricing methodology; vulnerability details; exploit code; cryptographic keys; authentication credentials; internal financial projections; acquisition strategy; personnel compensation and equity information; and any information designated "Highly Confidential" or "Restricted." Subject to additional handling requirements under §§ 2.5 and 4.
Confidential Information qualifying as a trade secret under the federal Defend Trade Secrets Act (18 U.S.C. § 1836 et seq.), the Delaware Uniform Trade Secrets Act (6 Del. C. § 2001 et seq.), or other applicable state trade secret law shall be treated as a trade secret for so long as it retains that status.
Confidential Information does not include information the Receiving Party can demonstrate by clear and convincing written evidence:
- (a)is or becomes publicly available through no breach of this Agreement;
- (b)was lawfully known to the Receiving Party without confidentiality restrictions before disclosure, evidenced by written records predating disclosure;
- (c)is independently developed without any use of or reference to the Disclosing Party's Confidential Information, evidenced by contemporaneous written records; or
- (d)is lawfully received from a third party not subject to confidentiality restrictions who had the right to disclose it.
No combination of non-confidential elements shall be excluded if the combination itself constitutes Confidential Information. The burden of proving any exclusion rests on the Receiving Party.
- Personnel / Representatives — current or former employees, officers, directors, founders, contractors, consultants, advisors, agents, subcontractors, attorneys, accountants, auditors, investors, lenders, and representatives bound by written confidentiality obligations at least as protective as this Agreement.
- AI Systems — any artificial intelligence, machine learning, foundation model, LLM, generative AI, autonomous agent, RAG system, embedding system, vector database, classifier, recommender, analytics model, automated decision system, fine-tuned model, or related software service.
- External AI Service — any AI System or AI-enabled service not fully controlled by the Receiving Party on its own infrastructure, including hosted models, public chatbots, coding assistants, copilots, transcription tools, meeting bots, note-taking tools, agent platforms, document analysis tools, and cloud AI APIs.
- Platform — AR's software products, services, APIs, demo environments, pilot systems, evaluation tools, reports, dashboards, integrations, and any other AR technology made available to Company under this Agreement.
- Authorized Users — Company's employees, contractors, and agents authorized by Company to access the Platform for the Purpose.
- Order Form / SOW — any written order, subscription confirmation, invoice, or related commercial document signed by both Parties specifying the scope, fees, term, and conditions of a paid engagement.
- Key Personnel — any founder, executive, lead engineer, principal researcher, or other identified senior AR employee who has been introduced to or become known to Company in connection with the Purpose.
The Receiving Party shall: (a) hold Confidential Information in strict confidence; (b) use it solely for the Purpose; (c) protect it using no less than commercially reasonable safeguards and at least the same care used for its own most sensitive proprietary information; (d) not disclose it except as expressly permitted; and (e) not use it to gain any competitive, commercial, legal, regulatory, financial, or other advantage over the Disclosing Party.
Access to Confidential Information is limited to Representatives with a genuine need to know for the Purpose. Highly Confidential Information may be accessed only by named or identifiable Representatives with minimum necessary access; the Receiving Party shall maintain reasonable written records of such access sufficient to support verification under § 4.6.
The Receiving Party shall ensure its Representatives comply with this Agreement and shall be liable for any breach by its Representatives as if committed by the Receiving Party directly.
Without prior written authorization, the Receiving Party shall not, and shall ensure its Representatives do not:
- (a)reverse engineer, disassemble, decompile, or derive source code, models, prompts, embeddings, trade secrets, algorithms, rules, or architecture from Confidential Information;
- (b)perform penetration testing, security research, vulnerability scanning, scraping, crawling, harvesting, load testing, or automated querying against the Disclosing Party's systems, software, APIs, or services;
- (c)combine Confidential Information with open-source software licensed under copyleft terms (GPL, AGPL, LGPL, EUPL, or similar) in a way that would subject Confidential Information to those terms (an "Open Source Contamination Event");
- (d)file any patent, trademark, or other IP application that claims, references, incorporates, or is enabled by the Disclosing Party's Confidential Information;
- (e)use Confidential Information to prepare competitive intelligence, investor materials, acquisition analyses, reverse-engineering analyses, or build-versus-buy analyses outside the Purpose; or
- (f)copy, reproduce, or create derivative works of Confidential Information except as strictly necessary for the Purpose.
The Receiving Party shall not store Highly Confidential Information in personal accounts, unmanaged devices, public repositories, shared drives without access controls, unsecured collaboration tools, or External AI Services. The Receiving Party shall not print Highly Confidential Information except as expressly authorized in writing. All permitted copies must retain all confidentiality notices.
The Receiving Party shall not use Confidential Information, directly or indirectly, to train, fine-tune, pre-train, prompt-tune, reinforce, evaluate, benchmark, validate, test, improve, distill, or otherwise develop any AI System, model, classifier, embedding system, vector database, synthetic-data generator, agent, or automated decision system, except with the Disclosing Party's prior written consent. This restriction covers use as training data, evaluation data, prompt engineering inputs, few-shot examples, and reference material during model development.
The Receiving Party shall not upload, submit, paste, transmit, or otherwise expose Confidential Information to any External AI Service — including public or hosted LLMs, coding assistants, copilots, transcription tools, meeting bots, note-taking tools, agent platforms, document analysis tools, or AI-enabled productivity tools — unless the Disclosing Party has provided prior written consent and the Receiving Party has confirmed in writing that: (a) the service's terms prohibit training on user content; (b) a valid data-processing agreement is in place; and (c) the data is encrypted end-to-end and not retained beyond the session.
Any embeddings, vectors, synthetic data, fine-tuned models, model weights, prompts, prompt chains, datasets, classifiers, evaluation sets, outputs, summaries, analyses, or other materials generated from or derived from the Disclosing Party's Confidential Information are deemed Confidential Information of the Disclosing Party. To the extent ownership does not automatically vest in the Disclosing Party, the Receiving Party hereby irrevocably assigns all right, title, and interest in such materials, including all intellectual property rights.
Outputs, logs, telemetry, traces, prompts, responses, evaluation records, red-team findings, policy decisions, agent actions, tool calls, and other data generated by or through AR products, demos, pilots, test environments, APIs, software, or services are Confidential Information of AR unless otherwise agreed in writing by AR.
The Receiving Party shall not publish, disclose, summarize, benchmark, compare, or distribute performance, security, vulnerability, reliability, pricing, product, or evaluation results concerning AR products, services, systems, software, demos, pilots, or Confidential Information without AR's prior written consent.
Source code, repository contents, build scripts, infrastructure-as-code, model code, configuration files, policies, detection rules, and related materials are Highly Confidential Information. The Receiving Party shall not copy, fork, clone, download, scrape, export, train on, test, compile, execute, benchmark, reverse engineer, or analyze such materials except as expressly authorized in writing.
During the Term and for three (3) years thereafter, Company shall not assert, threaten to assert, license, assign to an asserting party, or encourage the assertion of any patent claim against AR or any AR customer, partner, or user based on or enabled by information disclosed by AR under this Agreement. Company shall promptly notify AR if it becomes aware of any third party intending to assert such a claim.
If Company becomes aware of any potential Open Source Contamination Event, it shall notify AR within twenty-four (24) hours and cooperate fully with AR to assess, contain, and remediate the contamination at Company's expense.
The Receiving Party shall implement and maintain administrative, technical, and physical safeguards appropriate to the sensitivity of the Confidential Information, including: multi-factor authentication on all accounts that can access Confidential Information; least-privilege access controls; encryption in transit (TLS 1.2 or higher) and at rest (AES-256 or equivalent); endpoint protection; vulnerability management; secure configuration; logging and monitoring; access review; personnel training; secure deletion; and reasonable vendor-risk controls for any subprocessors that receive Confidential Information.
The Receiving Party shall promptly remediate known critical or high-risk vulnerabilities affecting systems that store, process, transmit, or access Confidential Information and shall not store Confidential Information in systems known to be materially insecure.
The Receiving Party shall notify the Disclosing Party in writing within forty-eight (48) hours after becoming aware of any actual or reasonably suspected unauthorized access to, acquisition, use, disclosure, loss, compromise, or misuse of Confidential Information. Notice shall describe: the nature of the incident; the Confidential Information affected; the systems affected; containment steps taken and planned; remediation steps; and a designated point of contact. Written updates every forty-eight (48) hours until fully contained and remediated.
The Receiving Party shall not provide regulated personal data (GDPR, CCPA, HIPAA, or FERPA), payment card data (PCI-DSS), export-controlled technical data, government classified information, or third-party confidential information to the Disclosing Party unless expressly authorized in writing and unless the Parties have agreed to any required additional data-processing or compliance terms.
Each Party shall comply with applicable U.S. federal and state privacy, cybersecurity, export-control, sanctions, trade-secret, employment, and data-protection laws, including the DTSA, the Computer Fraud and Abuse Act (18 U.S.C. § 1030), the CCPA and CPRA, and applicable state breach-notification laws.
Upon thirty (30) days' prior written notice (or immediately upon a material breach or suspected breach of § 3), AR may, at its own expense (or at Company's expense if a material breach is confirmed), conduct or commission a reasonable audit of Company's compliance, including review of access logs, deletion certifications, security configurations, AI system training records, and repository histories. Company shall cooperate fully, make relevant Personnel and records reasonably available, and promptly remediate any confirmed deficiencies. Audit materials are Highly Confidential Information. AR may exercise this right no more than once per twelve (12) months absent a material breach or suspected breach.
Company shall not share Confidential Information with any subprocessor, vendor, service provider, or third party unless: (a) AR has provided prior written consent; (b) the subprocessor is bound by written confidentiality obligations at least as protective as this Agreement; and (c) Company remains fully liable for any breach by such subprocessor.
If Company will access Highly Confidential Information or the Platform, Company shall maintain throughout the Term and for three (3) years thereafter:
- (a)Commercial general liability — not less than $1,000,000 per occurrence and $2,000,000 in the aggregate;
- (b)Cyber liability and data-breach — not less than $1,000,000 per occurrence;
- (c)Errors and omissions / professional liability — not less than $1,000,000 per occurrence.
Upon request, Company shall furnish certificates of insurance naming AR as an additional insured. Maintenance of insurance does not limit Company's indemnification or other obligations.
Company shall use the Platform only through Authorized Users and only for the Purpose within any agreed scope, volume, or term limits. Company shall not permit any person who is not an Authorized User to access the Platform using Company's credentials, accounts, or access tokens.
Company is responsible for all activity under its Platform accounts. Company shall: (a) maintain strong, unique credentials for each Authorized User account; (b) enable multi-factor authentication where offered by AR; (c) promptly revoke access of any Authorized User who no longer requires access or whose employment has ended; (d) not share credentials or API keys among multiple individuals; and (e) promptly notify AR if any credential or API key is or may have been compromised.
Company shall not, and shall ensure Authorized Users do not: (a) access the Platform in violation of any applicable law; (b) attempt to circumvent, bypass, or probe AR's access controls, rate limits, security measures, or usage metering; (c) use automated scripts, bots, crawlers, or tools to access the Platform in a manner not expressly authorized; (d) upload or transmit malicious code, malware, or exploits; (e) use the Platform to violate third-party rights; (f) resell, sublicense, or provide third-party access without AR's written consent; (g) attempt to extract AR's proprietary algorithms, detection logic, or model behavior through systematic querying or output analysis; or (h) use the Platform for any purpose other than the Purpose.
Company shall be fully responsible and liable for any Platform use by its Authorized Users, including any breach of this Section 5. Company shall promptly notify AR of any suspected unauthorized use of the Platform from Company's account.
AR may immediately suspend Company's access to the Platform, without liability, if AR reasonably determines that Company or any Authorized User is in material violation of this Section 5 or Section 10 (Payment). AR shall provide written notice of suspension promptly and restore access upon confirmation of cure.
Nothing in this Agreement grants, by implication, estoppel, exhaustion, or otherwise, any license, assignment, ownership interest, or other right in or to any Confidential Information, software, data, model, invention, patent, copyright, trade secret, trademark, know-how, or other intellectual property of the Disclosing Party, except the limited right to use Confidential Information solely for the Purpose during the Term.
All analyses, summaries, notes, extracts, compilations, translations, datasets, derivative works, evaluations, diagrams, prompt chains, embeddings, fine-tuned models, or other materials created by or for the Receiving Party that incorporate, are based on, reference, or derive from Confidential Information of the Disclosing Party shall be deemed Confidential Information of the Disclosing Party. The Receiving Party hereby irrevocably assigns to the Disclosing Party all right, title, and interest in such materials, including all copyrights, patents, trade secrets, and other intellectual property rights.
Each Party retains all right, title, and interest in its own pre-existing intellectual property. No Party receives ownership of the other Party's pre-existing IP by virtue of this Agreement. Nothing in this Agreement constitutes a work-for-hire arrangement.
If Company or its Representatives provide suggestions, ideas, comments, improvements, feature requests, bug reports, recommendations, or other feedback relating to AR products, services, software, business, or technology ("Feedback"), AR may use, disclose, reproduce, license, distribute, and commercialize such Feedback without restriction, attribution, or compensation. Company hereby irrevocably assigns to AR all right, title, and interest in Feedback. AR shall not disclose Company's identity in connection with Feedback without Company's consent.
No general residual-knowledge clause shall permit use of AR's trade secrets, source code, prompts, datasets, embeddings, model information, customer or prospect information, pricing, product roadmap, or security architecture. A Receiving Party may use only general skills and experience retained in unaided memory, provided such use does not reproduce, reference, rely on, disclose, or derive from Confidential Information; does not infringe or misappropriate IP; and does not enable competitive development based on Confidential Information. Unaided memory excludes information intentionally memorized to circumvent this Agreement.
During the Term and for three (3) years thereafter, the Receiving Party shall not, directly or indirectly, use Confidential Information to bypass, avoid, interfere with, or circumvent the Disclosing Party in connection with any customer, prospect, partner, investor, vendor, channel partner, reseller, acquisition target, financing source, product opportunity, integration opportunity, or business opportunity disclosed, identified, introduced, discussed, or made known through the Purpose.
The Receiving Party shall not use Confidential Information to solicit, divert, compete for, impair, or interfere with the Disclosing Party's customers, prospects, users, partners, suppliers, employees, contractors, investors, or business relationships.
The Receiving Party shall not use Confidential Information to create, fund, acquire, advise, assist, or commercialize a competing offering, internal project, or third-party project targeting an opportunity disclosed by the Disclosing Party, except through a written agreement with the Disclosing Party.
During the Term and for twenty-four (24) months thereafter, each Party shall not directly or indirectly solicit, recruit, induce, encourage, or assist in inducing any Personnel of the other Party who was introduced to or became known to the soliciting Party through the Purpose to terminate, reduce, or alter that person's relationship with the other Party or to seek employment with the soliciting Party or its affiliates.
To the maximum extent enforceable under applicable law, during the same restricted period, each Party shall not knowingly hire, engage, or retain as an employee, contractor, consultant, advisor, or other service provider any Key Personnel or other Personnel of the other Party who was introduced to or became known to the hiring Party through the Purpose, without the other Party's prior written consent.
§§ 8.1 and 8.2 do not apply to: (a) general public job postings or advertising campaigns not targeted at the other Party's Personnel; (b) Personnel who respond to general solicitations without direct or indirect targeted outreach; or (c) individuals whose relationship with the other Party ended at least six (6) months before first contact and who were not introduced to the hiring Party through the Purpose.
With respect to any Personnel who primarily reside or work in California, Minnesota, North Dakota, or Oklahoma, the non-hire provision of § 8.2 shall not apply to the extent prohibited by applicable state law, but all trade secret and confidentiality protections remain fully enforceable. If any restriction is limited by applicable law, it shall be modified to the maximum enforceable scope rather than voided.
If Company violates §§ 8.1 or 8.2 with respect to any AR Personnel, Company shall pay AR, as liquidated damages and not as a penalty, $250,000 per affected individual, which the Parties agree is a reasonable pre-estimate of harm. This amount is in addition to, and not in lieu of, any other remedies available to AR.
During the Term and for twelve (12) months thereafter, the Receiving Party shall not use Confidential Information to develop, build, train, finance, acquire, sell, license, support, benchmark, or bring to market a product or service directly competitive with products or services identified, demonstrated, or described by the Disclosing Party in connection with the Purpose. This restriction applies only to activities that use, rely on, reference, or are enabled by Confidential Information and does not prohibit independently developed activities.
The Receiving Party shall not use Confidential Information to prepare competitive intelligence, investor materials, acquisition analyses, analyst reports, market maps, product comparisons, reverse-engineering analyses, patent filings, employment recruiting plans, procurement leverage, or internal build-versus-buy analyses outside the Purpose.
The Parties request that any court or arbitrator modify any overbroad restriction to the maximum enforceable scope rather than invalidating it in its entirety.
This Agreement does not by itself require either Party to enter into a paid engagement. However, if the Parties enter into any paid pilot, proof of concept, evaluation, assessment, subscription, integration, implementation, consulting, support, reseller, partner, advisory, or services arrangement, all payment obligations, usage restrictions, confidentiality obligations, and IP protections applicable to that arrangement shall survive termination or expiration of this Agreement.
- Evaluation scope — Company shall not use AR software, APIs, reports, assessments, or services beyond the agreed evaluation scope or term; out-of-scope use may be charged at AR's then-current rates.
- Net 30, USD — invoices are due within thirty (30) days of invoice date, payable in U.S. dollars by wire transfer, ACH, or other method AR designates in writing.
- Late interest — 1.5% per month (or the legal maximum) on amounts unpaid after thirty (30) days, compounded monthly until paid in full.
- Suspension for non-payment — AR may suspend access to the Platform fifteen (15) days after written notice of an overdue undisputed amount.
- Invoice disputes — Company must notify AR in writing within fifteen (15) days of the invoice date; undisputed portions are due regardless of any pending dispute.
- Wire fraud prevention — Company shall verify any change in AR's payment instructions by telephone to a known AR number before acting on any email requesting changed routing or banking information.
- Collection costs — Company reimburses AR for reasonable attorneys' fees, collection agency fees, court costs, and arbitration costs if Company fails to pay amounts owed.
- No setoff — payment disputes do not excuse or suspend confidentiality, IP, security, return/destruction, non-circumvention, non-solicitation, or Platform conduct obligations.
- Taxes — all fees are exclusive of applicable taxes; Company is responsible for all taxes other than taxes based on AR's net income.
- Auto-renewal — paid subscriptions auto-renew for successive periods equal to the initial subscription term unless either Party provides thirty (30) days' written notice of non-renewal.
Upon written request by the Disclosing Party, or upon termination or expiration, the Receiving Party shall within ten (10) business days: (a) return all tangible materials containing Confidential Information; (b) permanently delete and securely destroy all electronic, digital, machine-readable, and AI-system copies, including any embeddings, fine-tuned model weights, vector database entries, cached outputs, and AI session logs derived from Confidential Information; (c) remove Confidential Information from collaboration systems, repositories, tickets, notes, External AI Services, vector databases, embeddings, caches, local devices, and personal accounts; and (d) deliver a written certification signed by an authorized officer confirming full completion, including specific confirmation that all AI-derived materials have been purged.
Backups — automatic backup copies may be retained solely until deleted in ordinary archival procedures, not accessed except for disaster recovery, and permanently deleted within ninety (90) days.
Verification — the Receiving Party shall provide reasonable written evidence demonstrating return, deletion, or destruction upon reasonable request and cooperate with reasonable verification requests.
Legal holds — if legally required to retain Confidential Information, the Receiving Party may retain only the minimum required portion, continue to protect it under this Agreement, not use it except as legally required, and notify the Disclosing Party of the retention obligation as soon as legally permissible.
If the Receiving Party is required by subpoena, court order, regulatory demand, governmental request, stock exchange rule, or applicable law to disclose Confidential Information, it shall: (a) provide prompt written notice to the Disclosing Party as soon as legally permissible and, where practicable, at least ten (10) business days before disclosure; (b) reasonably cooperate, at the Disclosing Party's expense, with efforts to seek a protective order, confidential treatment, sealing, or other relief; (c) disclose only the portion legally required and specifically compelled; and (d) request confidential treatment for all disclosed Confidential Information. Compliance with this Section does not waive any confidentiality, privilege, trade secret, or ownership rights.
Each Party represents and warrants that: (a) it has full power and authority to enter into this Agreement; (b) this Agreement has been duly authorized, executed, and delivered and constitutes a legal, valid, and binding obligation; and (c) entering into this Agreement does not violate any other agreement, court order, or legal obligation binding on that Party.
Each Party represents that it will not disclose to the other Party any third-party confidential information, regulated personal data, or restricted technical data unless authorized to do so and unless any required additional terms have been agreed in writing.
Each Party represents that its Representatives who access Confidential Information are or will be bound by written confidentiality, invention-assignment, and data-security obligations sufficient to protect the Disclosing Party's Confidential Information and IP to at least the same degree as this Agreement.
Each Party represents and warrants that: (a) it is not a Specially Designated National or Blocked Person on the OFAC Consolidated Sanctions List; (b) it is not located in, organized under the laws of, or ordinarily resident in a country or territory subject to comprehensive U.S. economic sanctions; (c) it is not owned or controlled, directly or indirectly, by any such person or entity; and (d) it will notify the other Party immediately if any of the foregoing representations becomes untrue during the Term.
Each Party represents, warrants, and covenants that it and its Personnel have not made, and will not make, any payment or transfer of value to any government official, government employee, political party, or political candidate in connection with this Agreement or the Purpose, in violation of the Foreign Corrupt Practices Act (15 U.S.C. §§ 78dd-1 et seq.), the UK Bribery Act 2010, or any other applicable anti-corruption law. Each Party shall maintain records sufficient to demonstrate compliance and shall permit the other Party to audit such records upon thirty (30) days' written request.
Company represents that the information it has provided about its ownership, control, and organizational structure is accurate and complete, and that Company is not directly or indirectly owned or controlled by any foreign government, state-owned enterprise, or OFAC-sanctioned entity. Company shall promptly notify AR of any material change in its ownership or control structure.
This Agreement begins on the Effective Date and continues for two (2) years unless earlier terminated by either Party upon thirty (30) days' prior written notice. Termination does not affect obligations arising before termination or obligations that survive.
Confidentiality obligations for trade secrets survive indefinitely for so long as the information retains trade secret status. Confidentiality obligations for Highly Confidential Information survive for seven (7) years after termination or expiration. Confidentiality obligations for other Confidential Information survive for five (5) years after termination or expiration.
The following Sections survive for the periods stated or, if no period is stated, indefinitely: §§ 1, 3.3, 3.7, 6, 7, 8, 9, 10, 11, 13, 15, 16, 17, 18, and 19.
Any restricted period under this Agreement shall be tolled and extended for any period during which a Party is in breach of the applicable restriction, to the maximum extent permitted by law.
The limitation of liability in § 15.1 does not apply to liability for:
- (a)breach of confidentiality obligations with respect to trade secrets or Highly Confidential Information (§§ 2 and 3);
- (b)unauthorized AI training, AI model misuse, open-source contamination, or IP theft (§§ 3 and 6);
- (c)indemnification obligations (§ 16.2);
- (d)payment obligations (§ 10);
- (e)liquidated damages (§§ 8.5 and 16.3);
- (f)breach of non-circumvention obligations (§ 7);
- (g)willful misconduct, gross negligence, or fraud;
- (h)violations of the Computer Fraud and Abuse Act, DTSA, or other applicable criminal or quasi-criminal law; or
- (i)death, personal injury, or property damage caused by negligence.
Each Party acknowledges that breach or threatened breach may cause irreparable harm for which monetary damages would be inadequate. The Disclosing Party is entitled to seek temporary, preliminary, and permanent injunctive relief, specific performance, and other equitable relief without posting bond or proving actual damages, in addition to all other remedies.
The Receiving Party shall defend, indemnify, and hold harmless the Disclosing Party and its officers, directors, employees, agents, successors, and assigns from and against all losses, damages, liabilities, claims, judgments, settlements, costs, and expenses, including reasonable attorneys' and expert fees, arising out of or relating to: (a) breach of this Agreement by the Receiving Party or its Representatives; (b) unauthorized use, disclosure, access, loss, or misuse of Confidential Information; (c) violation of AI, data, privacy, export, security, or acceptable-use restrictions; (d) infringement or misappropriation of intellectual property resulting from misuse of Confidential Information; (e) an Open Source Contamination Event; or (f) violation of anti-corruption representations (§ 13.5).
The following amounts represent a reasonable pre-estimate of harm, not a penalty:
These amounts are in addition to injunctive relief and any other remedies. The right to seek actual damages in excess of these amounts for willful or egregious violations is not waived. These provisions shall not apply to the extent prohibited by applicable law.
Attorneys' fees — the prevailing Party in any action, arbitration, or proceeding to enforce this Agreement is entitled to recover reasonable attorneys' fees, expert fees, costs, and expenses.
Cumulative remedies — remedies are cumulative and not exclusive. No delay or failure to enforce rights constitutes a waiver.
This Agreement and all claims, disputes, or causes of action arising out of or relating to this Agreement shall be governed by the laws of the State of Delaware and applicable U.S. federal law, without regard to conflict-of-laws principles that would require application of a different state's law.
Except as provided in § 17.3, any dispute, claim, or controversy arising out of or relating to this Agreement, including formation, interpretation, breach, validity, or enforceability, shall be finally resolved by binding arbitration administered by the American Arbitration Association (AAA) under its Commercial Arbitration Rules then in effect. The arbitration shall be conducted by a single arbitrator with experience in technology and intellectual property matters, seated in Wilmington, Delaware, and may be conducted remotely by videoconference at either Party's request. The arbitration, all filings, evidence, testimony, orders, and award shall be kept strictly confidential. Judgment on the award may be entered in any court of competent jurisdiction.
Notwithstanding § 17.2, either Party may seek emergency, interim, preliminary, or permanent injunctive relief, specific performance, preservation of evidence, or other equitable relief in the Delaware Court of Chancery or, if that court lacks subject-matter jurisdiction, in the U.S. District Court for the District of Delaware or another Delaware state court of competent jurisdiction. The Parties irrevocably consent to exclusive personal jurisdiction and venue in such courts for such relief.
All claims and disputes must be arbitrated individually. No class, collective, consolidated, or representative proceeding is permitted. The arbitrator has no authority to combine or aggregate claims or conduct class arbitration.
Each Party shall comply with applicable U.S. export-control, sanctions, and trade laws, including the Export Administration Regulations (EAR, 15 C.F.R. Parts 730–774); the International Traffic in Arms Regulations (ITAR, 22 C.F.R. Parts 120–130); and OFAC sanctions programs (31 C.F.R. Parts 500–598). Confidential Information may not be exported, re-exported, transferred, or disclosed to restricted persons, entities, countries, or end uses without required governmental authorization.
The Receiving Party shall not use Confidential Information for prohibited, restricted, military, surveillance, cyber-offensive, sanctions-evading, or unlawful AI or cybersecurity uses, or for any use requiring export authorization unless such authorization has been obtained in advance and the Disclosing Party has provided prior written consent.
Company represents that it is not subject to foreign government ownership, control, influence, or access (FOCI) in a manner that would require notification to or mitigation by any U.S. government agency, and shall promptly notify AR if FOCI status changes. Company shall not disclose AR's Confidential Information to any foreign government, state-owned enterprise, or entity operating under the direction of a foreign government without AR's prior written consent.
Neither Party shall be liable for delays or failures to perform obligations (other than payment obligations and confidentiality obligations) caused by events outside that Party's reasonable control, including acts of God, natural disasters, pandemics, war, terrorism, government action, or widespread infrastructure failure, provided the affected Party: (a) promptly notifies the other Party in writing describing the event and its expected duration; (b) uses commercially reasonable efforts to mitigate the impact and resume performance; and (c) resumes full performance as soon as reasonably practicable. Force majeure does not excuse or delay payment obligations, confidentiality obligations, or return and destruction obligations.
- No obligation to proceed — nothing in this Agreement obligates either Party to disclose information, enter into any further agreement, continue discussions, make or accept any offer, provide services, or consummate any transaction.
- Assignment — neither Party may assign this Agreement without the prior written consent of the other Party, except to an affiliate or in connection with a merger, acquisition, reorganization, financing, or sale of all or substantially all of its assets or business, provided the assignee assumes all obligations in writing. Any prohibited assignment is void.
- Notices — notices must be in writing and delivered by email with confirmed receipt, nationally recognized overnight courier, or certified mail. Legal notices to AR: info@ainforce.ai.
- Entire agreement — this Agreement supersedes prior and contemporaneous understandings regarding confidentiality and the Purpose. In a conflict with an Order Form, the Order Form controls for the specific commercial transaction, except that confidentiality, IP ownership, AI restrictions, non-circumvention, non-solicitation, export controls, and remedies provisions are not diminished unless the Order Form explicitly references and supersedes the specific provision by section number.
- Amendments — amendments require a written instrument signed by authorized representatives of both Parties. No click-wrap, browse-wrap, or unilateral policy update constitutes an amendment.
- Severability — if any provision is held invalid, illegal, or unenforceable, it shall be modified to the minimum extent necessary to make it enforceable and the remaining provisions shall remain in full force and effect.
- Waiver — no waiver is effective unless in writing and signed by the waiving Party. A waiver of one breach is not a waiver of any subsequent or similar breach.
In witness whereof, the Parties have executed this Agreement as of the Effective Date last written below.
The following individuals are authorized to access Highly Confidential Information on behalf of Company. This list must be updated in writing within five (5) business days of any change.
| Name | Title | Date Added | Date Removed | |
|---|---|---|---|---|